Inari Medical, Inc. (NARI)

46.99 +0.50 (+1.08%) 收市：04:00PM EDT

Inari Medical, Inc.

6001 Oak Canyon
Suite 100
Irvine, CA 92618
United States
877 923 4747
https://www.inarimedical.com

版塊: Healthcare
行業: Medical Devices
全職員工: 1,300

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Andrew J. Hykes	CEO, President & Director	1.54M	無	1973
Mr. Mitchell C. Hill	Chief Financial Officer	864.63k	4.78M	1959
Dr. Thomas M. Tu M.D.	Chief Medical Officer	865.63k	1.17M	1973
Mr. Paul A. Koehn	Senior Vice President of Operations	無	無	1963
Mr. Kevin Strange	Senior Vice President of Finance, Accounting, Strategy & Business Development	無	無	無
Mr. John Hsu C.F.A.	Vice President of Investor Relations	無	無	無
Ms. Angela Ahmad	General Counsel & Secretary	無	無	無
Mr. Eric Khairy	Senior Vice President of Marketing	無	無	無
Mr. Tim A. Benner	Senior VP of Sales & Senior VP of U.S. Sales	無	無	無
Ms. Tara Dunn	Senior VP & GM of LimFlow	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

公司管治

截至 2024年6月1日 止，Inari Medical, Inc. 的 ISS 管治質素評分為 6。 Pillar 分數正在審核中：2；董事會：6；股東權利：8；現金賠償：7。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。